Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The clinical trial NCT03914495, also known as the MILE study, is investigating the role of reprogramming the microbiome in the accumulation of liver fat in individuals with non-alcoholic fatty liver disease (NAFLD). The study aims to determine whether soluble fiber supplementation, specifically inulin, can help decrease liver fat in obese individuals
Primary outcome measures
Absolute Change in Liver Fat
…